Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/35—Ketones, e.g. benzophenone
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
  • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/02—Halogenated hydrocarbons
  • A61K31/025—Halogenated hydrocarbons carbocyclic
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/12—Ketones
  • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
  • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
  • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
  • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
  • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
  • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
  • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
  • A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
  • A61K2800/88—Two- or multipart kits

Definitions

• the present invention relates to one or more selected from the group consisting of ⁇ -alkyl isothiocyanate compounds, ⁇ -alkyl thioalkyl isothiocyanate compounds and ⁇ -phenol alkyl isothiocyanate compounds.
• the present invention relates to an anti-periodontal agent comprising an isothiocyanate-toy compound and a mint essential oil or mint essential oil component, and a food or beverage or oral hygiene agent containing the anti-periodontal agent.
• Periodontal disease is caused by infection with anaerobic gram-negative bacteria such as Borphyromonas gingivalis.
• Anaerobic gram-negative bacteria such as Borphyromonas gingivalis.
• the prevalence rate in Japan is increasing with age (Shimoyuki Hamada et al., “Oral Microbiology and Immunity”, Ishiyaku Shuppan Co., Ltd. p.291, 2000). It is a serious disease.
• Periodontal diseases include various types of diseases, such as chronic gingivitis, adolescent gingivitis, gestational gingivitis and acute necrotizing ulcerative gingivitis, gingivitis, adult periodontitis, There are early-onset periodontitis, rapidly progressive periodontitis, and refractory periodontitis, and an association between a specific disease type and a specific bacterium has been proposed.
• Porphyromonas gingivalis (hereinafter referred to as "Pg bacteria") is said to be a typical anaerobic gram-negative bacterium associated with periodontal disease.
• Pg bacteria Porphyromonas gingivalis
• a comprehensive treatment method that covers other bacteria including Pg bacteria is also included. And you must think about preventive measures.
• bacteria that have been suggested to be associated with periodontal disease include Actinobacillus actinomycetemcomitans. FF.niij), Prevotella'-Gresence (Prevotella nigrescens, hereinafter referred to as "Pn bacteria”) and Prevotella 'intermedia (hereinafter referred to as "Pi bacteria”).
• Pn bacteria Prevotella nigrescens, hereinafter referred to as "Pn bacteria”
• Pi bacteria Prevotella nigrescens
• Pi bacteria Prevotella 'intermedia
• Fn bacteria are detected at refractory sites with a high frequency of recurrence, and are also found in chronic gingivitis and adult periodontitis.
• Pi and Pn are adolescent and gestational gingivitis, acute necrotizing.
• Synthetic antibacterial agents are effective for the prevention and improvement of periodontal diseases, and in particular, drugs such as chlorhexidine hydrochloride are frequently used. Synthetic antibacterial agents are highly active against all microorganisms and can effectively inhibit the growth of periodontal disease bacteria, but there is a risk of disrupting the normal bacteria layer within the oral cavity. In particular, there is a need for caution when using repeatedly or taking for a long time, and there is a need for a naturally-derived and safe high-V anti-periodontal disease agent that can replace synthetic antibacterial agents.
• Patent Document 4 describes that gram-negative bacteria that grow in plaque can be prevented by inhibiting the formation of plaque, thereby preventing periodontal disease.
• the isothiocyana-toy compound is a characteristic component of the rust flavor, has a low fragrance threshold, and has a strong rust-like irritation, similar to the plant-derived antibacterial component of Patent Documents 1 to 3 above. Even if it could be expected to be effective enough in practical use, it was very powerful.
• Patent Document 1 Japanese Patent No. 2582736
• Patent Document 2 Japanese Patent Publication No. 7-25670
• Patent Document 3 Japanese Patent Laid-Open No. 2004-18470
• Patent Document 4 Japanese Patent No. 3749604
• the problem of the present invention is to solve the above-mentioned problems in the prior art, originate from ingredients in plants that have been used for food and have no safety problems, and have a unique spice-like fragrance.
• providing an anti-periodontal agent that has a high antibacterial effect against periodontal disease-causing bacteria and can prevent or treat periodontal disease and The purpose is to provide applied food and drink and oral hygiene.
• the present inventors have one or more selected from the group consisting of ⁇ -alkyl isothiocyanate compounds, ⁇ -alkyl thioalkyl isothiocyanates and ⁇ -alkyl alkyl isothiocyanate compounds. Used as an anti-periodontal agent when a mixture of two or more isothiocyanate-toy compounds and mint essential oil or mint essential oil components are exposed to periodontal disease-causing bacteria.
• the present invention has been found that it can be used as an anti-periodontal agent for preventing or treating periodontal disease in a safe and effective manner, taking into consideration the long-term dietary experience, as well as having antibacterial activity that can be used It came to complete.
• the present invention provides an ⁇ -alkenyl isothiocyanate compound represented by the following formula [1], an ⁇ alkylthioalkyl isothiocyanate compound represented by the following formula [2], and ⁇ -phenylalkyl isothiocyanate toy compound represented by the formula [3] includes one or more isothiocyanate toy compounds selected from the group and mint essential oil or mint essential oil component It is an anti-periodontal agent characterized by the above.
• m represents an integer of 1 to 10.
• n represents an integer of 1 to 10
• R represents a linear or branched alkyl group having 1 to 4 carbon atoms
• the present invention relates to an aryleno isothiocyanate, 3 butenole isothiocyanate, 4 pentyl isothiocyanate, 5-hexyl isothiocyanate, 6-heptyl isothiocyanate, methyl thiol.
• the present invention also relates to one or more compounds selected from the group consisting of 5-methylthiopentyl isothiocyanate, allyl isothiocyanate, and benzyl isothiocyanate, and mint. It is an anti-periodontal agent characterized by containing an essential oil or a mint essential oil component.
• mint essential oil or mint essential oil component strength peppermint essential oil, spearmint essential oil, menthol, menthone, carvone, menthyl acetate, 1,8-cineole, limonene, ⁇ -caryophyllene It is a mixture of at least one or two or more components selected from the group that also has strength; 0.01 parts of mint essential oil or mint essential oil component is added to 100 parts by weight of isothiocyana one toy compound, and LOOOO parts by weight Each is characterized by
• the present invention is a food or drink or oral hygiene agent containing the anti-periodontal disease agent, and a food or drink or oral hygiene agent containing 0.001 to 1% by mass of the anti-periodontal disease agent.
• the anti-periodontal disease agent of the present invention exhibits bactericidal action at a high concentration against the various periodontal disease-causing bacteria, and suppresses the growth of periodontal disease-causing bacteria even at a low concentration Therefore, it is effective as an anti-periodontal agent because it prevents and ameliorates the occurrence of gingival inflammation and malodor associated with the growth of periodontal disease-causing bacteria.
• the anti-periodontal agent of the present invention is a highly safe component because it is a natural isothiocyanate-toihi compound and mint essential oil component contained in the flavor component of wasabi that has long been used in food. .
• isothiocyana toy compound mint essential oil or mint essential oil component each have a unique flavor
• combining them together provides a remarkable antibacterial effect s. Since low effective concentrations of the agents are sufficient, they do not significantly impair their flavor to the final product. Therefore, it can be used by blending with food and drink such as confectionery and juice, or oral hygiene such as toothpaste and mouth rinse.
• FIG. 1 An isobologram showing the results of adding allyl isothiocyanate and 1-limonene to P. g.
• FIG. 2 An isobologram showing the results when 5-methylthiopentyl isothiocyanate and 1-limonene are added to P. g.
• FIG. 3 is an isobologram showing the results when benzyl isothiocyanate and 1-limonene are added to P. g.
• FIG. 4 An isobologram showing the results when 5-methylthiopentyl isothiocyanate and 1 menthol were added to P.i.
• FIG. 5 is an isobologram showing the results when 5-methylthiopentyl isothiocyanate and 1-limonene are added to P.i.
• FIG. 6 An isobologram showing the results when 5-methylthiopentyl isothiocyanate and 1-strength rubon were added to P.i.
• FIG. 7 is a graph showing the results of measuring changes in the number of bacteria over time after adding 5-methylthiopentyl isothiocyanate and 1-limonene to P. g.
• the loading force of 5-methylthiopentyl isothiocyanate is 65 ppm, the same as that of MIC, and that of 1-limonene is 350 ppm, the same as that of MIC.
• FIG. 8 is a graph showing the results of measuring changes in the number of bacteria over time after adding 5-methylthiopentyl isothiocyanate and 1-limonene to P.n bacteria.
• the addition amount of 5-methylthiopentinoisolethiocyanate is 50 ppm, the same as that of MIC, and that of 1-limonene is 350 ppm, the same as that of MIC of P. g. (The MIC of 1-limonene against P.n bacteria was as high as ⁇ m, so the MIC of P.g bacteria was used.)
• FIG. 9 is a graph showing the results of measuring changes in the number of bacteria over time after adding 5-methylthiopentyl isothiocyanate and 1-limonene to P.i bacteria.
• the addition amount of 5-methylthiopentylisothiocyanate is 50 ppm, the same as that of MIC, and that of 1-limonene is 350 ppm, the same as that of MIC in P. g. (1-Limonene was not active against P.i bacteria, so we used MIC with P. g.)
• the present invention is an anti-periodontal agent comprising an isothiocyanate-toy compound described in detail below and mint essential oil or a mint essential oil component.
• the isothiocyanate compound used in the present invention is selected from the group consisting of ⁇ -alkenyl isothiocyanate compound, ⁇ alkylthioalkyl isothiocyanate compound, and ⁇ -phenol alkyl isothiocyanate compound 1 Species or two or more isothiocyanate compounds.
• m represents a force representing an integer of 1 to 10 2 to 8 force S, and 2 to 4 is particularly preferable.
• Specific examples of the compound having the structure of the formula [1] include allyl isothiocyanate, 3 butenoreisothiocyanate, 4 pentenoreisothiocyanate, 5-hexenoreisothiocyanate, 6-heptul. Examples include isothiocyanate. Among these, 5-hexenylisothiocyanate is preferable from the viewpoint that the irritating odor is relatively weak and the residual fragrance property is relatively low.
• a method for synthesizing the compound is disclosed in, for example, Japanese Patent Application Laid-Open No. 2-221255.
• ⁇ is preferably a force 3 to 8 representing an integer of 1 to 10, and 4 to 7 is particularly preferable.
• R represents a linear or branched alkyl group having 1 to 4 carbon atoms. Preferred examples include methyl, ethyl, ⁇ -propyl, isopropyl, ⁇ -butyl, isobutyl, sec-butyl and the like. The methyl group is preferred because it has a relatively low residual fragrance with no flavor.
• Examples of the compound having the structure of the formula [2] include methylthiomethyl isothiocyanate, ethyl thiomethyl isothiocyanate, n-propyl thiomethyl isothiocyanate, isopropyl thiomethyl isothiocyanate, n —Butylthiomethyl isothiocyanate, Isobutyl thiomethyl isothiocyanate, sec—Butyl thiomethyl isothiocyanate, 2-Methinoretino thio isocyanate, 2-Ethino retino thioisocyanate 2-n-propylthioethyl isothiocyanate, 3-methylthiopropyl isothiocyanate, 4-methylthiobutyl isothiocyanate, 5-methylthiopentyl isothiocyanate, 6-methylthiohexyl isothiocyanate, 7-methylthioheptyl Isothiocyanate, 8— Chi Lucio
• 6-methylthiohexyl isothiocyanate and 5-methylthiopentyl isothiocyanate are preferred because they have a relatively low residual fragrance that does not add to the flavor.
• a method for synthesizing the compound is disclosed in, for example, JP-A-7-215931, and its outline is described in an inert solvent.
• n an integer from 3 to 10.
• p is a force representing an integer of 1 to 10, preferably 1 to 8, particularly preferably 1 or 2.
• the compound having the structure of the formula [3] include benzyl isothiocyanate and phenethyl isothiocyanate.
• benzyl isothiocyanate is preferred because of its relatively weak irritating odor and relatively low residual fragrance V.
• a method for synthesizing the compound is disclosed, for example, in JP-A-2-221255, the outline of which is outlined in an inert solvent,
• X represents a halogen atom such as bromine, chlorine or iodine
• Mint essential oil or mint essential oil component used in the present invention is composed of peppermint essential oil, menthol, menthone, carvone, menthyl acetate, 1,8-cineole, limonene, and / 3-caryophyllene power contained in spearmint essential oil. It is a mixture of at least one or more selected ingredients.
• the anti-periodontal disease agent of the present invention 0.01 to: LOOOO parts by weight, especially 10 to: LOOO parts by weight of mint essential oil or mint essential oil component is added to 100 parts by weight of the isothiocyana toy compound. It is preferred to obtain a synergistic effect of both components.
• Anti-periodontal agents are preservatives, stabilizers, excipients, additives, pigments, fragrances, antioxidants, ethanol, wetting agents, surfactants, abrasives, as long as the effects of the present invention are not impaired. Etc. can be blended appropriately.
• the anti-periodontal disease agent of the present invention can be applied by adding it to food or drink or oral hygiene agent.
• the dosage form of the oral hygiene agent to be added may be liquid, solid or semi-solid. It can be applied to dentifrices, troches, liquid or powdered mouthwashes, coating liquids, chewing gums and the like.
• soft drinks such as juice, and confectionery such as candy and chewing gum are suitable.
• the anti-periodontal agent of the present invention is used by adding to the final product so that the concentration is preferably 0.001 to 2% by mass, particularly preferably about 0.002 to 0.1% by mass. It is done. If the added amount is less than the lower limit mass, the periodontal disease inhibitory effect is not exerted.On the other hand, if the added amount exceeds the upper limit mass, a wasabi-like or mint stimulating odor is strongly felt. It may not be suitable for blending with oral hygiene agents.
• 35 g of 5 hexyl bromide was dissolved in 40 g of 1,3 dimethyl-2-imidazolidinone, 24 g of potassium thiocyanate and 5.5 g of calcium carbonate were added, and the mixture was heated and stirred at 75 ° C. for 1 hour.
• the mint essential oil component to be mixed with the above isothiocyanate is separated and refined from peppermint essential oil and spare mint essential oil, menthol, menthone, carvone, menthyl acetate, 1,8 cineole, limonene, 13 and so on. These are one A commercially available product can also be used.
• the strain used for the evaluation was a typical periodontal disease-causing bacterium Borphyromonas gingivalis ATCC33277 (American Type Culture Collection) which had been cryopreserved in advance. Pg tooth) and Fusobaterium 'Nucleatum subsp, nucleatum JCM8532 strain (Fn), Prevotella nigrescens JCM6322 strain (Pn) , Prevotella 'intermedia (Pre votella intermedia) JCM 12248 strain (Pi fungus).
• strains were inoculated into 5 ml of modified GAM liquid medium and pre-cultured at 37 ° C for 44 hours for Pg and Fn bacteria and 24 hours for Pi and Pn bacteria. These were then planted in a new modified GAM liquid medium and adjusted to a final viable cell count of 1.0 ⁇ 10 8 CFUZml.
• Antibacterial activity was measured by the microplate checkerboard method using the prepared bacterial solution and the sample dissolved in DMF.
• the pre-cultured bacterial solution was added to a modified GAM liquid medium in a 96-well microplate at 1.0 X 10 8 CFUZml, and the isothiocyanate toy compound adjusted to a predetermined concentration in a vertical row. Added well mixed.
• mint essential oil components adjusted to a predetermined concentration in a horizontal row were mixed well.
• First lane force in a single vertical row 2x dilution system by transferring to the following lane (right adjacent) with stepwise mixing Created a column.
• Next, a two-fold dilution series was created by transferring while mixing in stages from the first row of horizontal lanes to the following lanes (next to the bottom).
• a dilution series of the isothiocyanate compound was obtained in the horizontal direction, and a dilution series of the mint essential oil component and a dilution series of the mixture were formed in the vertical direction.
• they were sealed with a silicon plate seal and cultured at 37 ° C for 44 hours for P. g bacteria and 24 hours for P. i bacteria. All cultures and operations were performed in an anaerobic glove bot.
• Figure 1-6 shows the combined effect of each isothiocyanate-toy compound and mint essential oil component on the isobologram.
• the FIC (Fractional Inhibit Concentration) index and! /, Concept were used as indicators of the combined effect of the combination of the two agents of the present invention (Yutsu Therapy Handbook revised third edition, Yasushi Ueda, Shimizu Edited by Kihachiro, Nagai Shoten, P.97, 1986). Low FIC index value! It is said that the synergistic effect is high.
• the FIC index is expressed by the following formula.
• the number of tests was set 3 times. If the value including the error range is less than 1, synergistic action is taken, if 1, the action is added, and if it exceeds 1, the action is antagonism.
• Table 1 shows the FIC index for Pg bacteria of the isothiocyanate-toihi compound, which is a combination of allyl isothiocyanate, 5-methylthiopentyl isothiocyanate and benzyl isothiocyanate, and a mint essential oil component. . From the results in Table 1, the antibacterial effect more than a simple sum against P. g bacteria was observed in the mixture of each isothiocyanate compound and mint essential oil component.
• Toothpaste 1 containing 5-methylthiopentyl isothiocyanate and 1-limonene was obtained according to the following formulation. [0047] [Table 2]
• Toothpaste 2 was obtained by blending arylisothiocyanate in place of 5-methinoretiopentinoreisothiocyanate in the formulation of Example 1.
• Toothpaste 3 was obtained by blending and blending 6-methylthiohexyl isothiocyanate in place of 5-methylthiopentyl isothiocyanate in the formulation of Example 1.
• Toothpaste 4 was obtained by blending benzylisothiocyanate in place of 5-methylthiopentylisothiocyanate in the formulation of Example 1.
• Toothpaste 5 was obtained by blending 1 menthol instead of 1-limonene in the formulation of Example 1 [0053] [Example 6]
• Toothpaste 7 was obtained by adding 1 1, 8 cineole instead of 1-limonene in the formulation of Example 1.
• Toothpaste 8 was obtained by blending 1-carvone instead of 1-limonene in the formulation of Example 1.
• Toothpaste 9 was obtained by blending 1 menthyl acetate instead of 1-limonene in the formulation of Example 1.
• Toothpaste 10 was obtained by blending 1 ⁇ -strength riophyllene instead of 1-limonene in the formulation of Example 1.
• Chewing gum 1 containing 5-methylthiopentyl isothiocyanate of the present invention and 1-limonene was obtained according to the formulation shown in Table 4 below.
• Chewing gum 2 was obtained by blending allyl isothiocyanate instead of 5-methylthiopentyl isothiocyanate in the formulation of Example 11.
• Chewing gum 3 was obtained by blending 6-methylthiohexyl isothiocyanate in place of 5-methylthiopentyl isothiocyanate in the formulation of Example 11.
• Chewing gum 4 was obtained by blending benzylisothiocyanate in place of 5-methylthiopentylisothiocyanate in the formulation of Example 11.
• Chewing gum 5 was obtained by blending 1-menthol instead of 1-limonene in the formulation of Example 11.
• Chewing gum 6 was obtained by blending 1-menton instead of 1-limonene in the formulation of Example 11.
• Chewing gum 7 was obtained by blending 1 1, 8 cineole instead of 1-limonene in the formulation of Example 11.
• the mouth rinse 1 containing 5-methylthiopentyl isothiocyanate of the present invention and 1-limonene was obtained according to the formulation shown in Table 6 below.
• Mouthwash 2 was obtained by blending allyl isothiocyanate instead of 5-methylthiopentyl isothiocyanate in the formulation of Example 21.
• Mouthwash 3 was obtained by blending 6-methylthiohexyl isothiocyanate in place of 5-methylthiopentyl isothiocyanate in the formulation of Example 21.
• Mouthwash 4 was obtained by blending benzylisothiocyanate instead of 5-methylthiopentylisothiocyanate in the formulation of Example 21.
• Mouthwash 5 was obtained by blending 1-menthol instead of 1-limonene in the formulation of Example 21.
• Mouth cleaner 9 was obtained by blending 1 menthyl acetate instead of 1-limonene in the formulation of Example 21.
• Hard candy 1 containing 5-methylthiopentyl isothiocyanate of the present invention and 1-limonene was obtained according to the formulation shown in Table 8 below.
• Hard candy 2 was obtained by blending allyl isothiocyanate instead of 5-methylthiopentyl isothiocyanate in the formulation of Example 31.
• Hard candy 3 was obtained by blending and blending 6-methylthiohexyl isothiocyanate instead of 5-methylthiopentyl isothiocyanate in the formulation of Example 31.
• Hard candy 4 was obtained by blending benzyl isothiocyanate in place of 5-methylthiopentyl isothiocyanate in the formulation of Example 31.
• Hard candy 5 was obtained by blending 1 menthol instead of 1-limonene in the formulation of Example 31.
• Hard candy 6 was obtained by blending 1-menton instead of 1-limonene in the formulation of Example 31.
• Hard candy 7 was obtained by blending 1 1,8 cineole instead of 1-limonene in the formulation of Example 31. [Example 38]
• Hard candy 9 was obtained by blending 1 menthyl acetate in place of 1-limonene in the formulation of Example 31.
• Hard candy 10 was obtained by blending 1- ⁇ -caryophyllene instead of 1-limonene in the formulation of Example 31.
• Test Example 8 The results of Test Example 8 and Test Example 9 are shown in Table 9.
• the isothiocyana toihi compound has a flavor of mint essential oil component, but has a flavor that does not feel uncomfortable as a food product.
• the addition amount is small enough to have a sufficient effect, so it became clear that L, which does not significantly impair the flavor of the product.
• the anti-periodontal disease agent of the present invention is effective as a preventive agent for periodontal disease because it suppresses oral diseases caused by typical periodontal disease-causing bacteria.
• the anti-periodontal agent of the present invention is a natural product isothiocyanate toy compound and mint essential oil component contained in the wasabi flavor component. Therefore, the taste does not significantly affect the final product with high anti-periodontal disease effect despite its high safety and low addition amount! /.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Epidemiology (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Emergency Medicine (AREA)
• Birds (AREA)
• Dermatology (AREA)
• Engineering & Computer Science (AREA)
• Nutrition Science (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Food Science & Technology (AREA)
• Polymers & Plastics (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Mycology (AREA)
• Organic Chemistry (AREA)
• Botany (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Cosmetics (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines Containing Plant Substances (AREA)
• Coloring Foods And Improving Nutritive Qualities (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=38693898

Family Applications (1)

Country Status (2)

Cited By (3)

Families Citing this family (5)

Citations (5)

Family Cites Families (5)

• 2006
  • 2006-05-16 JP JP2006136164A patent/JP5091426B2/ja not_active Expired - Fee Related
• 2007
  • 2007-05-14 WO PCT/JP2007/059852 patent/WO2007132807A1/ja not_active Ceased

Patent Citations (5)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events